FamiCord AG (XTER:V3V) FCF Margin % : 12.06% (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is FamiCord AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. FamiCord AG's Free Cash Flow for the three months ended in Sep. 2024 was €2.68 Mil. FamiCord AG's Revenue for the three months ended in Sep. 2024 was €22.23 Mil. Therefore, FamiCord AG's FCF Margin % for the quarter that ended in Sep. 2024 was 12.06%.

As of today, FamiCord AG's current FCF Yield % is 12.50%.

The historical rank and industry rank for FamiCord AG's FCF Margin % or its related term are showing as below:

XTER:V3V' s FCF Margin % Range Over the Past 10 Years
Min: -15.84 Med: 8.91 Max: 27.43
Current: 11.13

During the past 13 years, the highest FCF Margin % of FamiCord AG was 27.43%. The lowest was -15.84%. And the median was 8.91%.

XTER:V3V's FCF Margin % is ranked better than
79.25% of 670 companies
in the Healthcare Providers & Services industry
Industry Median: 2.235 vs XTER:V3V: 11.13

FamiCord AG FCF Margin % Historical Data

The historical data trend for FamiCord AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FamiCord AG FCF Margin % Chart

FamiCord AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

27.43

14.67

1.65

-15.84

6.57

FamiCord AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															4.06	17.88	14.64	-0.34	12.06

Competitive Comparison of FamiCord AG's FCF Margin %

For the Medical Care Facilities subindustry, FamiCord AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FamiCord AG's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, FamiCord AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where FamiCord AG's FCF Margin % falls into.

Save Embed

;

Save Embed

;

FamiCord AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

FamiCord AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	5.063	/	77.062
	=	6.57 %

FamiCord AG's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	2.681	/	22.232
	=	12.06 %

FamiCord AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of FamiCord AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

FamiCord AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » FamiCord AG (XTER:V3V) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

V3V:Germany V3V:Germany V3V:Germany

Address

Perlickstrase 5, Leipzig, DEU, D-04103

Website

https://www.famicord.com

FamiCord AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Company is active in the areas of Cell & Gene therapies and CDMO. It continues to develop from a pure stem cell bank to a more broadly based cell bank that can supply the available patient's own cells for current and future cell therapies.

Executives

Jakub Julian Baran	Member of the Management Board
Dr. Alexander Granderath	Supervisory Board

FamiCord AG Headlines

No Headlines